

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | detection of molecule of bacterial origin (GO:0032490) | 4.69286872 |
| 2 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 4.66636329 |
| 3 | cellular extravasation (GO:0045123) | 4.13165555 |
| 4 | regulation of nitric-oxide synthase biosynthetic process (GO:0051769) | 4.01578337 |
| 5 | positive regulation by symbiont of host defense response (GO:0052509) | 3.96770447 |
| 6 | modulation by symbiont of host defense response (GO:0052031) | 3.96770447 |
| 7 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 3.96770447 |
| 8 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 3.96770447 |
| 9 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 3.96770447 |
| 10 | modulation by symbiont of host immune response (GO:0052553) | 3.96770447 |
| 11 | response to interferon-alpha (GO:0035455) | 3.86133012 |
| 12 | positive regulation of tumor necrosis factor biosynthetic process (GO:0042535) | 3.57287409 |
| 13 | macrophage activation involved in immune response (GO:0002281) | 3.55709820 |
| 14 | negative regulation of interleukin-12 production (GO:0032695) | 3.53371560 |
| 15 | response to peptidoglycan (GO:0032494) | 3.48663558 |
| 16 | neutrophil activation involved in immune response (GO:0002283) | 3.47345161 |
| 17 | cellular response to type I interferon (GO:0071357) | 3.37035976 |
| 18 | type I interferon signaling pathway (GO:0060337) | 3.37035976 |
| 19 | response to type I interferon (GO:0034340) | 3.33639912 |
| 20 | regulation of B cell receptor signaling pathway (GO:0050855) | 3.32636187 |
| 21 | membrane raft organization (GO:0031579) | 3.31809530 |
| 22 | wound healing, spreading of epidermal cells (GO:0035313) | 3.23978710 |
| 23 | microglial cell activation (GO:0001774) | 3.21995384 |
| 24 | positive regulation of interferon-alpha production (GO:0032727) | 3.19044873 |
| 25 | regulation of interferon-alpha production (GO:0032647) | 3.18869763 |
| 26 | detection of external biotic stimulus (GO:0098581) | 3.15668321 |
| 27 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 3.13031812 |
| 28 | response to host immune response (GO:0052572) | 3.13031812 |
| 29 | regulation of interferon-beta biosynthetic process (GO:0045357) | 3.08514370 |
| 30 | UDP-N-acetylglucosamine metabolic process (GO:0006047) | 3.05434898 |
| 31 | response to host (GO:0075136) | 3.04970731 |
| 32 | response to host defenses (GO:0052200) | 3.04970731 |
| 33 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 3.04970731 |
| 34 | retina vasculature morphogenesis in camera-type eye (GO:0061299) | 3.00701089 |
| 35 | positive regulation of toll-like receptor signaling pathway (GO:0034123) | 2.94952402 |
| 36 | cellular response to interferon-alpha (GO:0035457) | 2.92468864 |
| 37 | macrophage activation (GO:0042116) | 2.90345388 |
| 38 | cellular response to ethanol (GO:0071361) | 2.90157809 |
| 39 | positive regulation of interleukin-8 biosynthetic process (GO:0045416) | 2.89620924 |
| 40 | regulation of syncytium formation by plasma membrane fusion (GO:0060142) | 2.89341872 |
| 41 | regulation of tumor necrosis factor biosynthetic process (GO:0042534) | 2.89162110 |
| 42 | regulation of macrophage cytokine production (GO:0010935) | 2.88104175 |
| 43 | negative regulation of B cell proliferation (GO:0030889) | 2.87789938 |
| 44 | positive regulation of interferon-beta production (GO:0032728) | 2.85910885 |
| 45 | positive regulation of syncytium formation by plasma membrane fusion (GO:0060143) | 2.82238552 |
| 46 | regulation of platelet aggregation (GO:0090330) | 2.82072627 |
| 47 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 2.78081973 |
| 48 | cell adhesion mediated by integrin (GO:0033627) | 2.77685762 |
| 49 | detection of biotic stimulus (GO:0009595) | 2.76999693 |
| 50 | positive regulation of vasculogenesis (GO:2001214) | 2.72836072 |
| 51 | interleukin-6-mediated signaling pathway (GO:0070102) | 2.70242898 |
| 52 | positive regulation of macrophage cytokine production (GO:0060907) | 2.69149784 |
| 53 | substrate-dependent cell migration (GO:0006929) | 2.69118355 |
| 54 | wound healing, spreading of cells (GO:0044319) | 2.66232078 |
| 55 | phagocytosis, recognition (GO:0006910) | 2.65773136 |
| 56 | positive regulation of mast cell activation (GO:0033005) | 2.65765236 |
| 57 | B cell mediated immunity (GO:0019724) | 2.65259024 |
| 58 | positive regulation of gamma-delta T cell activation (GO:0046645) | 2.64793363 |
| 59 | detection of other organism (GO:0098543) | 2.64241219 |
| 60 | positive regulation of myeloid leukocyte cytokine production involved in immune response (GO:0061081 | 2.61756970 |
| 61 | phagocytosis, engulfment (GO:0006911) | 2.60522054 |
| 62 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 2.58783286 |
| 63 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 2.58651025 |
| 64 | intrinsic apoptotic signaling pathway in response to oxidative stress (GO:0008631) | 2.58190690 |
| 65 | response to muramyl dipeptide (GO:0032495) | 2.57617179 |
| 66 | regulation of mast cell activation (GO:0033003) | 2.55720441 |
| 67 | myeloid cell activation involved in immune response (GO:0002275) | 2.55402010 |
| 68 | interferon-gamma-mediated signaling pathway (GO:0060333) | 2.50161972 |
| 69 | sprouting angiogenesis (GO:0002040) | 2.50122880 |
| 70 | positive regulation of interleukin-8 secretion (GO:2000484) | 2.47939062 |
| 71 | negative regulation of cell killing (GO:0031342) | 2.47533787 |
| 72 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 2.47533787 |
| 73 | Rap protein signal transduction (GO:0032486) | 2.46994873 |
| 74 | histamine secretion (GO:0001821) | 2.46639376 |
| 75 | negative regulation of homotypic cell-cell adhesion (GO:0034111) | 2.45732857 |
| 76 | response to interferon-beta (GO:0035456) | 2.44996424 |
| 77 | immunoglobulin mediated immune response (GO:0016064) | 2.44833227 |
| 78 | positive regulation of interleukin-6 production (GO:0032755) | 2.43272427 |
| 79 | cellular response to exogenous dsRNA (GO:0071360) | 2.42016159 |
| 80 | platelet-derived growth factor receptor signaling pathway (GO:0048008) | 2.41229863 |
| 81 | T cell migration (GO:0072678) | 2.40186379 |
| 82 | regulation of T-helper 1 cell differentiation (GO:0045625) | 2.38974416 |
| 83 | negative regulation of nitric oxide biosynthetic process (GO:0045019) | 2.36835768 |
| 84 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 2.35800780 |
| 85 | antigen processing and presentation of endogenous antigen (GO:0019883) | 2.35362001 |
| 86 | response to hyperoxia (GO:0055093) | 2.34149436 |
| 87 | response to increased oxygen levels (GO:0036296) | 2.34149436 |
| 88 | negative regulation of interleukin-17 production (GO:0032700) | 2.33615193 |
| 89 | positive regulation of interleukin-1 beta secretion (GO:0050718) | 2.33264720 |
| 90 | superoxide anion generation (GO:0042554) | 2.32945189 |
| 91 | protein prenylation (GO:0018342) | 2.32002885 |
| 92 | prenylation (GO:0097354) | 2.32002885 |
| 93 | regulation of vasculogenesis (GO:2001212) | 2.28582523 |
| 94 | regulation of platelet activation (GO:0010543) | 2.28241979 |
| 95 | defense response to virus (GO:0051607) | 2.28170790 |
| 96 | neutrophil mediated immunity (GO:0002446) | 2.26932611 |
| 97 | regulation of interferon-beta production (GO:0032648) | 2.26504648 |
| 98 | endothelium development (GO:0003158) | 2.26058271 |
| 99 | dendritic cell migration (GO:0036336) | 2.25858091 |
| 100 | negative regulation of viral genome replication (GO:0045071) | 2.24946329 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 5.05570326 |
| 2 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 4.30191976 |
| 3 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 3.79213977 |
| 4 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 3.41690309 |
| 5 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 2.87128334 |
| 6 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 2.70384522 |
| 7 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 2.67052207 |
| 8 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.59526086 |
| 9 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 2.50473209 |
| 10 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 2.44737234 |
| 11 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 2.43230941 |
| 12 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.40823329 |
| 13 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 2.37342391 |
| 14 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 2.36767523 |
| 15 | BRD4_25478319_ChIP-Seq_HGPS_Human | 2.29050454 |
| 16 | CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 2.28148213 |
| 17 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 2.12849707 |
| 18 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.10830120 |
| 19 | * CJUN_26792858_Chip-Seq_BT549_Human | 2.03805402 |
| 20 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.02036661 |
| 21 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.91763034 |
| 22 | ELK1_19687146_ChIP-ChIP_HELA_Human | 1.84263739 |
| 23 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 1.81779594 |
| 24 | GATA1_22025678_ChIP-Seq_K562_Human | 1.79735318 |
| 25 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 1.79729194 |
| 26 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.76387760 |
| 27 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.69836387 |
| 28 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.69836387 |
| 29 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.67019327 |
| 30 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.66854398 |
| 31 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.66180684 |
| 32 | * RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.65387073 |
| 33 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 1.64555146 |
| 34 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.62282325 |
| 35 | TP53_16413492_ChIP-PET_HCT116_Human | 1.61748957 |
| 36 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.60480317 |
| 37 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 1.60065617 |
| 38 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 1.55990486 |
| 39 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 1.55990486 |
| 40 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.55944952 |
| 41 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 1.51161460 |
| 42 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.49001147 |
| 43 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.46351767 |
| 44 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.42365287 |
| 45 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.41737088 |
| 46 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.38999004 |
| 47 | TP53_18474530_ChIP-ChIP_U2OS_Human | 1.37313596 |
| 48 | * JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.36202592 |
| 49 | EWS_26573619_Chip-Seq_HEK293_Human | 1.36178001 |
| 50 | * JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.34867834 |
| 51 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.27656286 |
| 52 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.26812656 |
| 53 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.26502411 |
| 54 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.26492280 |
| 55 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.24775057 |
| 56 | MYB_26560356_Chip-Seq_TH2_Human | 1.22513231 |
| 57 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.21795488 |
| 58 | TP63_23658742_ChIP-Seq_EP156T_Human | 1.21549825 |
| 59 | P300_19829295_ChIP-Seq_ESCs_Human | 1.21351301 |
| 60 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 1.19799971 |
| 61 | CDX2_22108803_ChIP-Seq_LS180_Human | 1.18572286 |
| 62 | GATA3_26560356_Chip-Seq_TH2_Human | 1.17852906 |
| 63 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.17444100 |
| 64 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.13633308 |
| 65 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.13352050 |
| 66 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.12537389 |
| 67 | GBX2_23144817_ChIP-Seq_PC3_Human | 1.11893632 |
| 68 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.11058582 |
| 69 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.10448140 |
| 70 | SPI1_23127762_ChIP-Seq_K562_Human | 1.10089386 |
| 71 | SALL4_22934838_ChIP-ChIP_CD34+_Human | 1.09956112 |
| 72 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 1.09797361 |
| 73 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.09293338 |
| 74 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.09075607 |
| 75 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 1.04789071 |
| 76 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 1.04423778 |
| 77 | * MYB_26560356_Chip-Seq_TH1_Human | 1.03537126 |
| 78 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.02928224 |
| 79 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.02429393 |
| 80 | FOXM1_26456572_ChIP-Seq_MCF-7_Human | 1.00692054 |
| 81 | ATF3_23680149_ChIP-Seq_GBM1-GSC_Human | 0.99808221 |
| 82 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 0.97422527 |
| 83 | SCL_19346495_ChIP-Seq_HPC-7_Human | 0.96452912 |
| 84 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 0.95817225 |
| 85 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 0.93958882 |
| 86 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 0.93917305 |
| 87 | * TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.92955145 |
| 88 | SMAD4_21799915_ChIP-Seq_A2780_Human | 0.92744711 |
| 89 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 0.91460266 |
| 90 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.91206240 |
| 91 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 0.90938069 |
| 92 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 0.90606474 |
| 93 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 0.90484405 |
| 94 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 0.90319927 |
| 95 | STAT3_23295773_ChIP-Seq_U87_Human | 0.90242705 |
| 96 | CRX_20693478_ChIP-Seq_RETINA_Mouse | 0.89695703 |
| 97 | VDR_22108803_ChIP-Seq_LS180_Human | 0.88267118 |
| 98 | TFEB_21752829_ChIP-Seq_HELA_Human | 0.87692402 |
| 99 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 0.87535944 |
| 100 | ELK1_22589737_ChIP-Seq_MCF10A_Human | 0.86960950 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0006054_spinal_hemorrhage | 3.62704023 |
| 2 | MP0003724_increased_susceptibility_to | 3.28146599 |
| 3 | MP0003950_abnormal_plasma_membrane | 3.02314725 |
| 4 | MP0008438_abnormal_cutaneous_collagen | 2.92258613 |
| 5 | MP0001835_abnormal_antigen_presentation | 2.81935298 |
| 6 | MP0003828_pulmonary_edema | 2.78021126 |
| 7 | MP0000569_abnormal_digit_pigmentation | 2.58787138 |
| 8 | MP0003279_aneurysm | 2.51765233 |
| 9 | MP0004272_abnormal_basement_membrane | 2.51458038 |
| 10 | MP0006082_CNS_inflammation | 2.20702531 |
| 11 | MP0003191_abnormal_cellular_cholesterol | 2.14451006 |
| 12 | MP0003303_peritoneal_inflammation | 2.13722730 |
| 13 | MP0003566_abnormal_cell_adhesion | 2.12311850 |
| 14 | MP0010368_abnormal_lymphatic_system | 2.11019920 |
| 15 | MP0003300_gastrointestinal_ulcer | 2.03506538 |
| 16 | MP0003091_abnormal_cell_migration | 1.97794230 |
| 17 | MP0000685_abnormal_immune_system | 1.83998840 |
| 18 | MP0002419_abnormal_innate_immunity | 1.83912831 |
| 19 | MP0009785_altered_susceptibility_to | 1.83249489 |
| 20 | MP0002148_abnormal_hypersensitivity_rea | 1.80823635 |
| 21 | MP0010352_gastrointestinal_tract_polyps | 1.80518296 |
| 22 | MP0009764_decreased_sensitivity_to | 1.72387409 |
| 23 | MP0008260_abnormal_autophagy | 1.69342797 |
| 24 | MP0005464_abnormal_platelet_physiology | 1.66315390 |
| 25 | MP0005164_abnormal_response_to | 1.65875098 |
| 26 | MP0002452_abnormal_antigen_presenting | 1.65751847 |
| 27 | MP0003436_decreased_susceptibility_to | 1.58851600 |
| 28 | MP0003705_abnormal_hypodermis_morpholog | 1.58819535 |
| 29 | MP0001790_abnormal_immune_system | 1.58605565 |
| 30 | MP0005387_immune_system_phenotype | 1.58605565 |
| 31 | MP0001800_abnormal_humoral_immune | 1.55959515 |
| 32 | MP0000343_altered_response_to | 1.55711929 |
| 33 | MP0002723_abnormal_immune_serum | 1.53346638 |
| 34 | MP0004883_abnormal_blood_vessel | 1.53180406 |
| 35 | MP0005000_abnormal_immune_tolerance | 1.50284307 |
| 36 | MP0000015_abnormal_ear_pigmentation | 1.50264011 |
| 37 | MP0003045_fibrosis | 1.45669327 |
| 38 | MP0001879_abnormal_lymphatic_vessel | 1.43018104 |
| 39 | MP0003448_altered_tumor_morphology | 1.42630988 |
| 40 | MP0005275_abnormal_skin_tensile | 1.40636698 |
| 41 | MP0001533_abnormal_skeleton_physiology | 1.40059754 |
| 42 | MP0000767_abnormal_smooth_muscle | 1.38954882 |
| 43 | MP0005623_abnormal_meninges_morphology | 1.37678952 |
| 44 | MP0005025_abnormal_response_to | 1.37588199 |
| 45 | MP0002405_respiratory_system_inflammati | 1.35002777 |
| 46 | MP0005023_abnormal_wound_healing | 1.34339526 |
| 47 | MP0001819_abnormal_immune_cell | 1.31464685 |
| 48 | MP0002420_abnormal_adaptive_immunity | 1.30684788 |
| 49 | MP0005310_abnormal_salivary_gland | 1.29898510 |
| 50 | MP0001958_emphysema | 1.28555554 |
| 51 | MP0000858_altered_metastatic_potential | 1.25048934 |
| 52 | MP0008057_abnormal_DNA_replication | 1.23257360 |
| 53 | MP0005397_hematopoietic_system_phenotyp | 1.22591710 |
| 54 | MP0001545_abnormal_hematopoietic_system | 1.22591710 |
| 55 | MP0002168_other_aberrant_phenotype | 1.17772506 |
| 56 | MP0002254_reproductive_system_inflammat | 1.17495446 |
| 57 | MP0001853_heart_inflammation | 1.16823215 |
| 58 | MP0005174_abnormal_tail_pigmentation | 1.15284228 |
| 59 | MP0005595_abnormal_vascular_smooth | 1.14083929 |
| 60 | MP0005671_abnormal_response_to | 1.12988710 |
| 61 | MP0005171_absent_coat_pigmentation | 1.12685919 |
| 62 | MP0003941_abnormal_skin_development | 1.12265357 |
| 63 | MP0002332_abnormal_exercise_endurance | 1.12118323 |
| 64 | MP0001542_abnormal_bone_strength | 1.07308974 |
| 65 | MP0003763_abnormal_thymus_physiology | 1.06193681 |
| 66 | MP0001915_intracranial_hemorrhage | 1.05005056 |
| 67 | MP0001845_abnormal_inflammatory_respons | 1.04949727 |
| 68 | MP0000465_gastrointestinal_hemorrhage | 1.03707901 |
| 69 | MP0004947_skin_inflammation | 1.03394326 |
| 70 | MP0000249_abnormal_blood_vessel | 1.02840778 |
| 71 | MP0002998_abnormal_bone_remodeling | 1.01077353 |
| 72 | MP0002396_abnormal_hematopoietic_system | 0.99932714 |
| 73 | MP0004808_abnormal_hematopoietic_stem | 0.99239958 |
| 74 | MP0009384_cardiac_valve_regurgitation | 0.98517349 |
| 75 | MP0000716_abnormal_immune_system | 0.96376377 |
| 76 | MP0002877_abnormal_melanocyte_morpholog | 0.95473799 |
| 77 | MP0004484_altered_response_of | 0.95199738 |
| 78 | MP0001851_eye_inflammation | 0.94902538 |
| 79 | MP0002398_abnormal_bone_marrow | 0.93715357 |
| 80 | MP0002133_abnormal_respiratory_system | 0.93360942 |
| 81 | MP0005388_respiratory_system_phenotype | 0.93360942 |
| 82 | MP0008469_abnormal_protein_level | 0.90249259 |
| 83 | MP0008004_abnormal_stomach_pH | 0.90161475 |
| 84 | MP0005165_increased_susceptibility_to | 0.89909998 |
| 85 | MP0010155_abnormal_intestine_physiology | 0.89761058 |
| 86 | MP0002166_altered_tumor_susceptibility | 0.88171329 |
| 87 | MP0000371_diluted_coat_color | 0.86202579 |
| 88 | MP0002006_tumorigenesis | 0.85017684 |
| 89 | MP0009697_abnormal_copulation | 0.81657408 |
| 90 | MP0002138_abnormal_hepatobiliary_system | 0.81404190 |
| 91 | MP0005390_skeleton_phenotype | 0.80861853 |
| 92 | MP0000689_abnormal_spleen_morphology | 0.80377130 |
| 93 | MP0002429_abnormal_blood_cell | 0.77428242 |
| 94 | MP0003183_abnormal_peptide_metabolism | 0.77343666 |
| 95 | MP0005621_abnormal_cell_physiology | 0.77143109 |
| 96 | MP0002722_abnormal_immune_system | 0.76524448 |
| 97 | MP0005408_hypopigmentation | 0.76408782 |
| 98 | MP0002928_abnormal_bile_duct | 0.76013864 |
| 99 | MP0005167_abnormal_blood-brain_barrier | 0.75721599 |
| 100 | MP0002295_abnormal_pulmonary_circulatio | 0.75451089 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Spontaneous hematomas (HP:0007420) | 3.83678243 |
| 2 | Recurrent bacterial skin infections (HP:0005406) | 3.55241515 |
| 3 | Hematochezia (HP:0002573) | 3.49240901 |
| 4 | Orchitis (HP:0100796) | 3.38998823 |
| 5 | Spondylolisthesis (HP:0003302) | 3.38025950 |
| 6 | Peritonitis (HP:0002586) | 3.37527277 |
| 7 | Aortic dissection (HP:0002647) | 3.34170536 |
| 8 | Myositis (HP:0100614) | 3.33481588 |
| 9 | Aortic aneurysm (HP:0004942) | 3.29111035 |
| 10 | Optic neuritis (HP:0100653) | 3.21976957 |
| 11 | Retrobulbar optic neuritis (HP:0100654) | 3.21976957 |
| 12 | Abnormality of T cell number (HP:0011839) | 3.19232488 |
| 13 | Recurrent abscess formation (HP:0002722) | 3.15476335 |
| 14 | Premature rupture of membranes (HP:0001788) | 3.06202340 |
| 15 | Vascular tortuosity (HP:0004948) | 3.00439926 |
| 16 | Arterial tortuosity (HP:0005116) | 2.98785854 |
| 17 | T lymphocytopenia (HP:0005403) | 2.89406781 |
| 18 | Abnormality of macrophages (HP:0004311) | 2.84704337 |
| 19 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 2.81717907 |
| 20 | Osteolytic defects of the hand bones (HP:0009699) | 2.81717907 |
| 21 | Abnormal platelet volume (HP:0011876) | 2.79016113 |
| 22 | Conjunctival telangiectasia (HP:0000524) | 2.78425106 |
| 23 | Increased mean platelet volume (HP:0011877) | 2.78118299 |
| 24 | Myocardial infarction (HP:0001658) | 2.74671428 |
| 25 | Thoracolumbar scoliosis (HP:0002944) | 2.74169131 |
| 26 | Abnormality of the vasculature of the conjunctiva (HP:0008054) | 2.71044866 |
| 27 | Facial diplegia (HP:0001349) | 2.65912391 |
| 28 | Recurrent cutaneous fungal infections (HP:0011370) | 2.56338112 |
| 29 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.56338112 |
| 30 | Eczematoid dermatitis (HP:0000976) | 2.55851394 |
| 31 | Subacute progressive viral hepatitis (HP:0006572) | 2.54150209 |
| 32 | Elevated erythrocyte sedimentation rate (HP:0003565) | 2.54002064 |
| 33 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 2.50705137 |
| 34 | Delayed closure of the anterior fontanelle (HP:0001476) | 2.50693958 |
| 35 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.47775158 |
| 36 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.47775158 |
| 37 | Abnormality of glycolipid metabolism (HP:0010969) | 2.47775158 |
| 38 | Hemoptysis (HP:0002105) | 2.44968568 |
| 39 | Recurrent skin infections (HP:0001581) | 2.44132262 |
| 40 | Gastrointestinal infarctions (HP:0005244) | 2.43555191 |
| 41 | Absent frontal sinuses (HP:0002688) | 2.43509350 |
| 42 | Aplasia/Hypoplasia involving the sinuses (HP:0009120) | 2.41259054 |
| 43 | Autoimmune thrombocytopenia (HP:0001973) | 2.38698329 |
| 44 | Dilatation of the ascending aorta (HP:0005111) | 2.36020653 |
| 45 | Amaurosis fugax (HP:0100576) | 2.32929207 |
| 46 | Recurrent fungal infections (HP:0002841) | 2.32073346 |
| 47 | Autoimmune hemolytic anemia (HP:0001890) | 2.27589202 |
| 48 | Choroideremia (HP:0001139) | 2.25725732 |
| 49 | Follicular hyperkeratosis (HP:0007502) | 2.22900592 |
| 50 | Aplasia/Hypoplasia of the frontal sinuses (HP:0009119) | 2.20848223 |
| 51 | Pulmonary infiltrates (HP:0002113) | 2.20218558 |
| 52 | Vertebral arch anomaly (HP:0008438) | 2.19909839 |
| 53 | Eosinophilia (HP:0001880) | 2.17501103 |
| 54 | Basal ganglia calcification (HP:0002135) | 2.17157300 |
| 55 | Mucosal telangiectasiae (HP:0100579) | 2.13074318 |
| 56 | Arterial thrombosis (HP:0004420) | 2.12402544 |
| 57 | Aortic regurgitation (HP:0001659) | 2.11313988 |
| 58 | Cutaneous melanoma (HP:0012056) | 2.10819911 |
| 59 | Albinism (HP:0001022) | 2.10594062 |
| 60 | Soft skin (HP:0000977) | 2.10076077 |
| 61 | Thick nail (HP:0001805) | 2.09971397 |
| 62 | Prolonged bleeding time (HP:0003010) | 2.09685902 |
| 63 | Epistaxis (HP:0000421) | 2.09475194 |
| 64 | Vasculitis (HP:0002633) | 2.05986129 |
| 65 | Keratoconjunctivitis sicca (HP:0001097) | 2.05949650 |
| 66 | Protrusio acetabuli (HP:0003179) | 2.04860958 |
| 67 | Keratoconjunctivitis (HP:0001096) | 2.02981781 |
| 68 | Entropion (HP:0000621) | 2.01493259 |
| 69 | Tetraparesis (HP:0002273) | 2.00837947 |
| 70 | Aortic valve stenosis (HP:0001650) | 1.99228190 |
| 71 | Increased IgM level (HP:0003496) | 1.98175517 |
| 72 | Abnormal auditory evoked potentials (HP:0006958) | 1.97371610 |
| 73 | Portal hypertension (HP:0001409) | 1.96949614 |
| 74 | Recurrent viral infections (HP:0004429) | 1.96025072 |
| 75 | Poikiloderma (HP:0001029) | 1.95247824 |
| 76 | Abnormality of the peritoneum (HP:0002585) | 1.94128352 |
| 77 | Broad ribs (HP:0000885) | 1.93325770 |
| 78 | Hypoplasia of the iris (HP:0007676) | 1.91546852 |
| 79 | Chest pain (HP:0100749) | 1.90245206 |
| 80 | Thrombocytosis (HP:0001894) | 1.88619015 |
| 81 | IgA deficiency (HP:0002720) | 1.88158943 |
| 82 | Leukocytosis (HP:0001974) | 1.88001269 |
| 83 | Periodontitis (HP:0000704) | 1.87322908 |
| 84 | Abnormality of T cells (HP:0002843) | 1.86355413 |
| 85 | Fatigue (HP:0012378) | 1.85969059 |
| 86 | Prostate neoplasm (HP:0100787) | 1.84565219 |
| 87 | Abnormality of the frontal sinuses (HP:0002687) | 1.84313161 |
| 88 | Cerebral hemorrhage (HP:0001342) | 1.84167830 |
| 89 | Abnormality of the pericardium (HP:0001697) | 1.84051030 |
| 90 | Porencephaly (HP:0002132) | 1.82790143 |
| 91 | Recurrent bronchitis (HP:0002837) | 1.82175845 |
| 92 | Cervical subluxation (HP:0003308) | 1.81544967 |
| 93 | Persistence of primary teeth (HP:0006335) | 1.77924608 |
| 94 | Viral hepatitis (HP:0006562) | 1.76318743 |
| 95 | Ankle contracture (HP:0006466) | 1.75267319 |
| 96 | Keratitis (HP:0000491) | 1.75069318 |
| 97 | Atrophic scars (HP:0001075) | 1.75057116 |
| 98 | Premature loss of primary teeth (HP:0006323) | 1.74589265 |
| 99 | Deep philtrum (HP:0002002) | 1.74501811 |
| 100 | Spinal cord lesions (HP:0100561) | 1.74191838 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | FRK | 3.62993409 |
| 2 | BLK | 3.01258219 |
| 3 | TGFBR2 | 2.61064731 |
| 4 | TYK2 | 2.43820750 |
| 5 | TAF1 | 2.41139187 |
| 6 | TIE1 | 2.37644132 |
| 7 | MYLK | 2.22043520 |
| 8 | JAK3 | 2.11654335 |
| 9 | MST4 | 2.06232458 |
| 10 | BRSK2 | 2.05789631 |
| 11 | ACVR1B | 2.03083855 |
| 12 | ERBB4 | 1.94585441 |
| 13 | MAP3K14 | 1.91581343 |
| 14 | JAK1 | 1.91405427 |
| 15 | PIK3CG | 1.87012861 |
| 16 | TEC | 1.85527341 |
| 17 | EIF2AK3 | 1.79127501 |
| 18 | MAP3K3 | 1.77881430 |
| 19 | GRK7 | 1.75388614 |
| 20 | CSK | 1.71032204 |
| 21 | IRAK4 | 1.69689716 |
| 22 | NEK9 | 1.66997100 |
| 23 | FGR | 1.53853542 |
| 24 | NUAK1 | 1.53069061 |
| 25 | MAP3K12 | 1.50430292 |
| 26 | STK3 | 1.48830514 |
| 27 | MAP2K3 | 1.46942653 |
| 28 | BMPR2 | 1.44096231 |
| 29 | MELK | 1.38279417 |
| 30 | YES1 | 1.35894086 |
| 31 | KIT | 1.35484281 |
| 32 | PTK2B | 1.33888534 |
| 33 | IKBKE | 1.30366277 |
| 34 | WEE1 | 1.29878855 |
| 35 | STK10 | 1.25378476 |
| 36 | NEK1 | 1.22658474 |
| 37 | ZAP70 | 1.17398831 |
| 38 | IRAK1 | 1.14060446 |
| 39 | TGFBR1 | 1.13896212 |
| 40 | TRIM28 | 1.09047501 |
| 41 | PAK4 | 1.05856757 |
| 42 | RIPK4 | 1.03618265 |
| 43 | ADRBK2 | 1.02954820 |
| 44 | HCK | 1.02359554 |
| 45 | IKBKB | 1.00883306 |
| 46 | SIK3 | 1.00511025 |
| 47 | MARK3 | 0.99763675 |
| 48 | FER | 0.98763919 |
| 49 | NLK | 0.97526744 |
| 50 | TXK | 0.96157304 |
| 51 | MOS | 0.95021577 |
| 52 | PLK2 | 0.93831989 |
| 53 | BTK | 0.92761672 |
| 54 | PDGFRB | 0.92715542 |
| 55 | TBK1 | 0.91287632 |
| 56 | TRPM7 | 0.87468345 |
| 57 | LYN | 0.84056798 |
| 58 | DDR2 | 0.84054258 |
| 59 | MAPK7 | 0.83747269 |
| 60 | BMPR1B | 0.82555306 |
| 61 | EIF2AK2 | 0.79901503 |
| 62 | ADRBK1 | 0.79793873 |
| 63 | PLK3 | 0.78903087 |
| 64 | PAK2 | 0.78307304 |
| 65 | LATS1 | 0.77845390 |
| 66 | MKNK2 | 0.77704944 |
| 67 | PDGFRA | 0.76589760 |
| 68 | SYK | 0.73433030 |
| 69 | EGFR | 0.73085053 |
| 70 | JAK2 | 0.72973810 |
| 71 | TTN | 0.72778899 |
| 72 | CSF1R | 0.71619941 |
| 73 | GRK5 | 0.69231475 |
| 74 | FES | 0.68756850 |
| 75 | LCK | 0.66721009 |
| 76 | BCR | 0.66355314 |
| 77 | CDK6 | 0.62339252 |
| 78 | EPHB1 | 0.60957924 |
| 79 | MKNK1 | 0.59594491 |
| 80 | PTK2 | 0.57173372 |
| 81 | FLT3 | 0.57016262 |
| 82 | CLK1 | 0.56670795 |
| 83 | CAMKK2 | 0.56061787 |
| 84 | KSR1 | 0.55597947 |
| 85 | STK38 | 0.52917168 |
| 86 | ABL1 | 0.52506076 |
| 87 | EIF2AK1 | 0.51826337 |
| 88 | ERBB3 | 0.50653271 |
| 89 | TSSK6 | 0.48117112 |
| 90 | MET | 0.47411273 |
| 91 | MAP3K2 | 0.46910638 |
| 92 | IGF1R | 0.46909319 |
| 93 | STK38L | 0.45611796 |
| 94 | STK24 | 0.44364378 |
| 95 | INSR | 0.41277472 |
| 96 | NEK2 | 0.40561334 |
| 97 | ITK | 0.39984597 |
| 98 | PRKCE | 0.39770927 |
| 99 | GSK3A | 0.39392022 |
| 100 | BRD4 | 0.38576937 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 2.50777787 |
| 2 | Leishmaniasis_Homo sapiens_hsa05140 | 2.36155907 |
| 3 | Graft-versus-host disease_Homo sapiens_hsa05332 | 2.05306508 |
| 4 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.95692497 |
| 5 | Malaria_Homo sapiens_hsa05144 | 1.95178389 |
| 6 | Allograft rejection_Homo sapiens_hsa05330 | 1.94627581 |
| 7 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.93924400 |
| 8 | Measles_Homo sapiens_hsa05162 | 1.93533338 |
| 9 | Legionellosis_Homo sapiens_hsa05134 | 1.92568369 |
| 10 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.88269943 |
| 11 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.87317962 |
| 12 | p53 signaling pathway_Homo sapiens_hsa04115 | 1.83347957 |
| 13 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.82821761 |
| 14 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.79524235 |
| 15 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.77252258 |
| 16 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.76176054 |
| 17 | Influenza A_Homo sapiens_hsa05164 | 1.75122029 |
| 18 | Tuberculosis_Homo sapiens_hsa05152 | 1.74932240 |
| 19 | Viral myocarditis_Homo sapiens_hsa05416 | 1.70155867 |
| 20 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.63013429 |
| 21 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.62407998 |
| 22 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.61324033 |
| 23 | Asthma_Homo sapiens_hsa05310 | 1.61317400 |
| 24 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.54380700 |
| 25 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.53478288 |
| 26 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.47979467 |
| 27 | Platelet activation_Homo sapiens_hsa04611 | 1.47592337 |
| 28 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.45426573 |
| 29 | ECM-receptor interaction_Homo sapiens_hsa04512 | 1.45377339 |
| 30 | Hepatitis B_Homo sapiens_hsa05161 | 1.40241155 |
| 31 | Focal adhesion_Homo sapiens_hsa04510 | 1.38744727 |
| 32 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.38051191 |
| 33 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.37461026 |
| 34 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.36135769 |
| 35 | Small cell lung cancer_Homo sapiens_hsa05222 | 1.35284284 |
| 36 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.33614635 |
| 37 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.28741047 |
| 38 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.25496226 |
| 39 | Phagosome_Homo sapiens_hsa04145 | 1.24003652 |
| 40 | Shigellosis_Homo sapiens_hsa05131 | 1.23793162 |
| 41 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.22391775 |
| 42 | African trypanosomiasis_Homo sapiens_hsa05143 | 1.20361211 |
| 43 | Apoptosis_Homo sapiens_hsa04210 | 1.17634484 |
| 44 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 1.17100964 |
| 45 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 1.16663474 |
| 46 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.12525664 |
| 47 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 1.11265290 |
| 48 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.10144035 |
| 49 | Pertussis_Homo sapiens_hsa05133 | 1.09861747 |
| 50 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 1.06672402 |
| 51 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 1.04548348 |
| 52 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 1.03618919 |
| 53 | Amoebiasis_Homo sapiens_hsa05146 | 1.03577512 |
| 54 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.01788574 |
| 55 | Lysosome_Homo sapiens_hsa04142 | 1.01114752 |
| 56 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.96276451 |
| 57 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.90174510 |
| 58 | Salmonella infection_Homo sapiens_hsa05132 | 0.88481837 |
| 59 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.88312537 |
| 60 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.87940184 |
| 61 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.86126700 |
| 62 | Adherens junction_Homo sapiens_hsa04520 | 0.85095135 |
| 63 | Hepatitis C_Homo sapiens_hsa05160 | 0.84800535 |
| 64 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.81583908 |
| 65 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 0.80667116 |
| 66 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.80213618 |
| 67 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.79374107 |
| 68 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.78552603 |
| 69 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 0.72729945 |
| 70 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.66724587 |
| 71 | Basal transcription factors_Homo sapiens_hsa03022 | 0.63753522 |
| 72 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.63683134 |
| 73 | Prostate cancer_Homo sapiens_hsa05215 | 0.62709636 |
| 74 | HTLV-I infection_Homo sapiens_hsa05166 | 0.62356590 |
| 75 | Other glycan degradation_Homo sapiens_hsa00511 | 0.62005003 |
| 76 | Pathways in cancer_Homo sapiens_hsa05200 | 0.61572963 |
| 77 | PI3K-Akt signaling pathway_Homo sapiens_hsa04151 | 0.61559763 |
| 78 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.61146184 |
| 79 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.59569363 |
| 80 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.58587110 |
| 81 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.57899427 |
| 82 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.56639979 |
| 83 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.53271993 |
| 84 | Bladder cancer_Homo sapiens_hsa05219 | 0.49964648 |
| 85 | Melanoma_Homo sapiens_hsa05218 | 0.48749361 |
| 86 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.46834812 |
| 87 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.45789431 |
| 88 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.44824500 |
| 89 | Endocytosis_Homo sapiens_hsa04144 | 0.44462503 |
| 90 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.43232406 |
| 91 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.42646714 |
| 92 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.40045936 |
| 93 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.39616786 |
| 94 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 0.38884620 |
| 95 | Homologous recombination_Homo sapiens_hsa03440 | 0.38870095 |
| 96 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.37758504 |
| 97 | Non-homologous end-joining_Homo sapiens_hsa03450 | 0.37203772 |
| 98 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.37151788 |
| 99 | Proteasome_Homo sapiens_hsa03050 | 0.36759806 |
| 100 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.35768607 |

